rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Daiichi Sankyo

Rediff.com  »  News  »   Daiichi Sankyo

  News for Daiichi Sankyo

  • News
  • Business

Abe, Singh to meet today; investment deals likely

The annual summit between India and Japan on Saturday will seek to forge greater bilateral trade and investment ties, with Japanese Prime Minister Shinzo Abe coming with a high-powered business......

Ranbaxy staff get pay-cut shield in Sun buyout

The agreement agreed to by Sun Pharmaceutical Industries for a buyout of Ranbaxy Laboratories from Daiichi Sankyo provides for a year's 'cooling period' during which the pay of Ranbaxy employees......

Daiichi files plea in HC to vacate stay on Sun-Ranbaxy merger

Daiichi Sankyo, owner of Ranbaxy  Laboratories Limited, has filed a petition in Andhra Pradesh High Court requesting it to vacate the 'status quo' order it issued earlier on Sun Pharma-Ranbaxy......

Daiichi and Docomo go, but India remains a hot market for the Japanese

The decision of two marquee Japanese names -- Daiichi Sankyo and NTT Docomo -- to exit their Indian investments might give an impression that investors from that country are treading cautiously on......

Is Dilip Shanghvi's big bet worth the risk?

Ranbaxy's frequent run-ins with the US FDA may have proved too much for its previous owner, Japan's Daiichi Sankyo, but for Sun Pharma, it is an astute purchase that it hopes will not only boost......

Singh brothers count on disclosure to counter Daiichi claims

Facing arbitration claims by Daiichi Sankyo, Ranbaxy's former Indian promoters - Malvinder Mohan Singh, his brother Shivinder Mohan Singh and family - are counting on certain clauses in the share......

  People speak for daiichi sankyo

  • QNA
Q. Ranbaxy to delist---news. How far will it be beneficial to the Indian shareholders? Your views?
:  A. it would be of benefit to the shareholders of the company but the value addition expected over the long term will be missed out due to this as it...... more

http://qna.rediff.com/questions-and-answers/ranbaxy-to-delist---news.-how-far-will-it-be-beneficial-to-t//answers/16835060

Good Citizen
Q. Japanese company who has purchased Ranbaxy offering higher price of ranbaxy share from the open market. Could we hold the shares or sale to Japanese company ?
Good Citizen:  A. Daiichi Sankyo Co. is the Japanese company that recently purchased Ranbaxy labs. more

http://qna.rediff.com/questions-and-answers/japanese-company-who-has-purchased-ranbaxy-offering-higher-p/16830692/answers/10926389

DrKumarChatterjea
Q. tax Implications of Ranbaxy and Daiichi Sankyo deal.
DrKumarChatterjea :  A. none,,, it will b on stock exchange more

http://qna.rediff.com/questions-and-answers/tax-implications-of-ranbaxy-and-daiichi-sankyo-deal./10926270/answers/9516022

  Web results for Daiichi Sankyo
Daiichi Sankyo, UCB to jointly commercialise lacosamide for epilepsy patients in Japan

Daiichi Sankyo and UCB Biopharma SPRL have announced that the companies entered into an agreement to jointly commercialise Lacosamide for epilepsy... ...

http://www.pharmabiz.com/NewsDetails.aspx?aid=85362&sid=2
Sun-Ranbaxy deal to materialise by year end

Even as the Competition Commission of India (CCI) is looking at remedies that could be prescribed so that the Sun-Ranbaxy merger doesn't stifle... ...

http://www.pharmabiz.com/NewsDetails.aspx?aid=85349&sid=1
European Cardiologists Highlight Risk of Delayed Diagnosis for Patients with Non-Valvular Atrial Fibrillation

From the Wires Nov. 27, 2014 02:01 AM MUNICH , November 27, 2014 /PRNewswire/ -- Survey findings show that 97% of European cardiologists... ...

http://in.sys-con.com/node/3243485
Pulmonary Embolism Therapeutic Pipeline Market Drugs and Companies Review H2 2014

PRWeb 2014-11-26 RnRMarketReserach.com adds Pulmonary Embolism Pipeline Review, H2 2014 to its store. The analysis provides an overview of the... ...

http://www.bizwireexpress.com/showstoryPRWeb.php?storyid=331890
Sanjeev Dani, Rajiv Gulati quit Ranbaxy as senior management churn continues

NEW DELHI: In a sustained churn at Ranbaxy Laboratories, Sanjeev Dani, head of global strategy, corporate and business development, and Rajiv... ...

http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sanjeev-dani-rajiv-gulati-quit-ranbaxy-as-senior-management-churn-continues/articleshow/45291029.cms

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Related Pages


daiichi sankyo
Daiichi Sankyo

Company
0 Followers

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z